Blog

Medical device manufacturers have become all too familiar with the scrutiny that coincides with their controversial products. However, none may be more accustomed to the criticism that follows the release of medical devices than that of Johnson & Johnson (J&J). As the current industry leader in medical device production, J&J has seen an influx…

In October 2010, the U.S. Food & Drug Administration in association with Godi International, Corp. and PRock Marketing LLC announced a nationwide recall of the Fruta Planta weight loss dietary supplement after receiving reports of serious, life-threatening cardiac complications and one death. If you or a loved one has been injured by Fruta Planta,…

C.R. Bard Inc. is scheduled to face its first federal court trial early next year over allegations that the company’s transvaginal mesh (TVM) devices injured recipients. A trial date of Feb. 5, 2013, has been set for the first of approximately 600 federal lawsuits alleging that Bard’s Avaulta implant caused severe organ damage. U.S….

Oral Sodium Phosphate medications used prior to colonoscopies have been linked to serious, life-threatening kidney injuries and/or kidney failure. These kidney problems are also known as acute phosphate nephropathy. If you or a loved one has been injured by an OSP, you should contact our lawyersimmediately for a free confidential case evaluation. You may…

A large number of colonoscopy patients have suffered from serious kidney damage (acute phosphate nephropathy) after using OsmoPrep bowel cleansing product. Given the serious nature of the injuries consumers were reporting, in 2008 the FDA required a black box warning be added to the labeling of this product. If you or a loved one…

Birth control pills that contain drospirenone, otherwise known as fourth generation oral contraceptives, have recently become the subject of increasing distain within the healthcare community. Reports indicate that the use of such contraceptives may coincide with catastrophic complications. Of significant concern, however, is their recent association with the development of severe, life-threatening blood clots….

Victoza (generic: liraglutide) was approved by the U.S. Food and Drug Administration (FDA) to serve as a once-daily injection for the treatment of type 2 diabetes in some adults. Of significant concern, however, are the serious side effects that have recently been associated with clinically relevant Victoza exposure. Subsequently, Victoza treatment may place patients…

Recent years have witnessed several antidepressant medications become the subject of increasingly critical skepticism. Compounding the criticism further are reports of new evidence that lends weight tot he long-suspected link between selective serotonin reuptake inhibitors (SSRIs) and congenital birth defects. According to a new study, the risk of a child developing persistent pulmonary hypertension…